UConn and JAX Study: Why is COVID-19 Deadlier for Older Adults?

UConn and JAX Study: Why is COVID-19 Deadlier for Older Adults?

Here is Renee's conversation about this important partnership and study with Jacques Banchereau, Ph.D., Professor and Director, Immunological Sciences at The Jackson Laboratory, and George Kuchel, MD CM, FRCP, Director, UConn Center of Aging, University of Connecticut, Chief, Geriatric Medicine, UConn Health.

Listen here:

George Kuchel, MD CM, FRCP, Director, UConn Center of Aging, University of Connecticut, Chief, Geriatric Medicine, UConn Health.

Jacques Banchereau, Ph.D., Professor and Director, Immunological Sciences at The Jackson Laboratory

UConn and The Jackson Laboratory are currently looking for participants in this study:

  • Looking for participants who have not yet received their first vaccination. Preferred no history of Covid-19
  • Looking for volunteers from three distinct age ranges: 21-49 years old, 50-64, and 65+. The age ranges were chosen to reflect the changes in the immune system that begin in late middle age. To join the study, you need to be a healthy adult who hasn’t yet been vaccinated against COVID-19, but has scheduled an appointment to do so. Volunteers for the study will be asked to give a little blood before they get vaccinated and have their noses swabbed, and then come back again to do the same thing a few weeks afterwards. 
  • The study is enrolling now. Anyone interested in participating should contact the UConn Center on Aging, (860) 679-3043, email Megan Wing, wing@uchc.edu or call JAX study coordinators at 860-837-2404.

Click here to read more about the study!

Photos: UConn, The Jackson Laboratory


Sponsored Content

Sponsored Content